abstract |
The present invention relates to the use of sodium / hydrogene exchange inhibitors in the manufacture of medicaments for use in the treatment of dysfunctional or chronic dosing agents in the treatment of acute unwanted effects on the heart or in veterinary medicine. According to the invention, various benzylglynidine derivatives are preferably used as sodium / hydrogens exchange inhibitors. ŕ |